These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7460515)

  • 1. [Postural variations in aldosterone secretion. Clinical and physiopathological studies in a normal subject and in a case of primary hyperaldosteronism].
    Herpin D; Bauplé JL; Rouffineau J; Demange J
    Coeur Med Interne; 1980; 19(2):199-205. PubMed ID: 7460515
    [No Abstract]   [Full Text] [Related]  

  • 2. Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.
    Ganguly A; Grim CE; Weinberger MH
    N Engl J Med; 1981 Oct; 305(17):991-3. PubMed ID: 6268979
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of aldosterone secretion in primary aldosteronism.
    Vetter H; Vetter W
    Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
    Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.
    Carey RM; Sen S; Dolan LM; Malchoff CD; Bumpus FM
    N Engl J Med; 1984 Jul; 311(2):94-100. PubMed ID: 6330549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
    Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
    J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
    Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-suppressible hyperaldosteronism: a clue to the missing hormone?
    Mulrow PJ
    N Engl J Med; 1981 Oct; 305(17):1012-4. PubMed ID: 6268977
    [No Abstract]   [Full Text] [Related]  

  • 10. Local Control of Aldosterone Production and Primary Aldosteronism.
    Lalli E; Barhanin J; Zennaro MC; Warth R
    Trends Endocrinol Metab; 2016 Mar; 27(3):123-131. PubMed ID: 26803728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic hyperaldosteronism and the related dexamethasone suppressive hyperaldosteronism].
    Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):517-22. PubMed ID: 1320089
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
    Jungmann E; Althoff PH; Rosak C; Schwedes U; Schöffling K
    Horm Metab Res; 1986 Feb; 18(2):138-40. PubMed ID: 3699687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New data on the regulation of aldosterone secretion (aldosterone-stimulating factor and the dopaminergic system)].
    Kirilov G
    Eksp Med Morfol; 1988; 27(4):58-63. PubMed ID: 3069456
    [No Abstract]   [Full Text] [Related]  

  • 14. Missing endogenous dopaminergic inhibition of aldosterone secretion in human CONN's adenoma tissue after heterotransplantation to thymusaplastic mice.
    Jungmann E; Schwedes U; Usadel KH; Obert I; Schöffling K
    Horm Metab Res; 1983 Aug; 15(8):413. PubMed ID: 6311710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
    Shkhvatsabaia IK; Pershakova LP; Ustinova SE; Chikhladze NM; Uchitel' IA
    Kardiologiia; 1985 Jan; 25(1):16-22. PubMed ID: 2984449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopaminergic mechanisms in regulating the release of renin and aldosterone in arterial hypertension].
    Bicho MP
    Rev Port Cardiol; 1988; 7(2):215-20. PubMed ID: 3078730
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
    Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
    J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
    Mune T; Morita H; Yasuda K; Yamakita N; Miura K
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism].
    Salvador M; Chamontin B; Rostaing L; Salva P
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):992-4. PubMed ID: 3117000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of aldosterone secretion rate by radio-immunoassay.
    Bayard F; Beitins IZ; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1970 Nov; 31(5):507-11. PubMed ID: 5470209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.